Time to Count Recovery after Post-Remission Chemotherapy in AML Patients

被引：0
|
作者：
Paras, Gabrielle [1 ]
Othus, Megan [2 ,3 ]
Shaw, Carole M. [4 ]
Russell, Katie [5 ]
Halpern, Anna B. [6 ,7 ]
Appelbaum, Jacob S. [6 ,7 ]
Hendrie, Paul C. [1 ,7 ]
Walter, Roland B. [1 ,4 ,8 ]
Percival, Mary-Elizabeth M. [1 ,5 ]
机构：
[1] Univ Washington, Dept Med, Seattle, WA 98195 USA
[2] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA
[3] Fred Hutchinson Canc Res Ctr, Div Publ Hlth, 1124 Columbia St, Seattle, WA 98104 USA
[4] Fred Hutchinson Canc Res Ctr, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA
[5] Fred Hutchinson Canc Ctr, Seattle, WA USA
[6] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA
[7] Fred Hutchinson Canc Ctr, Clin Res Div, Seattle, WA USA
[8] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-157586
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6080 / 6081
页数：2
相关论文
共 50 条
  • [1] Optimal post-remission consolidation therapy in patients with AML
    Jimenez-Chillon, Carlos
    Dillon, Richard
    Russell, Nigel
    [J]. ACTA HAEMATOLOGICA, 2024, 147 (02) : 148 - 159
  • [2] High-dose chemotherapy with autologous PDSCT as post-remission therapy for AML
    M Harada
    H Gondo
    F Kawano
    [J]. Bone Marrow Transplantation, 2001, 27 : 347 - 347
  • [3] High-dose chemotherapy with autologous PBSCT as post-remission therapy for AML
    Harada, M
    Gondo, H
    Kawano, F
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 (03) : 347 - 347
  • [4] Retrospective analysis of post-remission modalities in AML patients with normal karyotype
    Chae, Yee Soo
    Sohn, Sang Kyun
    Kim, Jong Gwang
    Cho, Yoon Young
    Moon, Joon Ho
    Ahn, Byung Min
    Kim, Shi Nae
    [J]. BLOOD, 2007, 110 (11) : 132B - 132B
  • [5] Cost comparison of post-remission strategies in younger and older AML patients in France
    Mounie, Michael
    Dumas, Pierre-Yves
    Liva-Yonnet, Sandra
    Fabre, Didier
    Leguay, Thibault
    Galtier, Jean
    Berard, Emilie
    Hanta, Ramaroson
    Gilleron, Veronique
    Bertoli, Sarah
    Pigneux, Arnaud
    Recher, Christian
    Costa, Nadege
    [J]. BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [6] BIOMARKER BASED POST-REMISSION STRATEGY IMPROVES THE OUTCOME OF ADULT AML PATIENTS
    Di Veroli, A.
    Buccisano, F.
    Maurillo, L.
    Piciocchi, A.
    Picardi, A.
    Cerretti, R.
    Del Principe, M. I.
    De Bellis, E.
    De Angelis, G.
    Cudillo, L.
    Cicconi, L.
    Rossi, V.
    Voso, M. T.
    Lo Coco, F.
    Amadori, S.
    Arcese, W.
    Venditti, A.
    [J]. HAEMATOLOGICA, 2017, 102 : 70 - 70
  • [7] Cost comparison of post-remission strategies in younger and older AML patients in France
    Michael Mounie
    Pierre-Yves Dumas
    Sandra Liva-Yonnet
    Didier Fabre
    Thibault Leguay
    Jean Galtier
    Emilie Berard
    Ramaroson Hanta
    Véronique Gilleron
    Sarah Bertoli
    Arnaud Pigneux
    Christian Récher
    Nadège Costa
    [J]. Blood Cancer Journal, 13
  • [8] The role of post-remission chemotherapy for older patients with acute myelogenous leukemia
    Abou-Jawde, RM
    Sobecks, R
    Pohlman, B
    Rybicki, L
    Advani, A
    Sekeres, M
    Kalaycio, M
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (04) : 689 - 695
  • [9] Fluoroquinolone Prophylaxis in Acute Myeloid Leukemia (AML) Patients Undergoing Post-Remission Chemotherapy Reduces Hospital Admission Rates
    Kusick, Karissa
    Earl, Marc
    Gallagher, Erika M.
    Yeh, Jun-Yen
    Advani, Anjali S.
    Kalaycio, Matt
    Copelan, Edward A.
    Sekeres, Mikkael A.
    [J]. BLOOD, 2011, 118 (21) : 1103 - 1103
  • [10] Should older adults with AML receive post-remission therapy?
    Stone, Richard M.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2015, 28 (2-3) : 106 - 111
12345